TARNA Trademark

Trademark Overview


On Wednesday, April 27, 2022, a trademark application was filed for TARNA with the United States Patent and Trademark Office. The USPTO has given the TARNA trademark a serial number of 79348883. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, September 4, 2024. This trademark is owned by TargImmune Therapeutics AG. The TARNA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, pharmaceutical development and research as well as research and design services relating thereto; scientific industrial analysis and industrial scientific research services; providing information and data in relation to scientific and technological research and development; scientific and technological services, namely, pharmaceutical development and research and scientific research services in the field of developing immunological, pharmaceutical, immunotherapeutic and diagnostic products, in particular immunological, pharmaceutical and immunotherapeutic products, in particular for the prevention and treatment of oncological diseases; scientific and technological services and scientific research in the field of discovery, development and formulation of chemical synthesis and medicinal products, in particular for immunological, pharmaceutical and immunotherapeutic products, in particular for the prevention and treatment of oncological dise...
tarna

General Information


Serial Number79348883
Word MarkTARNA
Filing DateWednesday, April 27, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, September 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific and technological services, namely, pharmaceutical development and research as well as research and design services relating thereto; scientific industrial analysis and industrial scientific research services; providing information and data in relation to scientific and technological research and development; scientific and technological services, namely, pharmaceutical development and research and scientific research services in the field of developing immunological, pharmaceutical, immunotherapeutic and diagnostic products, in particular immunological, pharmaceutical and immunotherapeutic products, in particular for the prevention and treatment of oncological diseases; scientific and technological services and scientific research in the field of discovery, development and formulation of chemical synthesis and medicinal products, in particular for immunological, pharmaceutical and immunotherapeutic products, in particular for the prevention and treatment of oncological diseases

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 14, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTargImmune Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, September 8, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 13, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Wednesday, February 15, 2023ASSIGNED TO EXAMINER
Wednesday, September 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 20, 2022APPLICATION FILING RECEIPT MAILED
Wednesday, February 22, 2023NON-FINAL ACTION WRITTEN
Thursday, February 23, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 13, 2023REFUSAL PROCESSED BY MPU
Thursday, April 13, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, May 2, 2023REFUSAL PROCESSED BY IB
Friday, October 13, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 13, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 12, 2024NON-FINAL ACTION WRITTEN
Wednesday, December 6, 2023ASSIGNED TO EXAMINER
Friday, January 12, 2024NON-FINAL ACTION E-MAILED
Friday, January 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 21, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 21, 2024NON-FINAL ACTION E-MAILED
Wednesday, February 21, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, March 3, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, February 14, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 14, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, March 18, 2024REFUSAL PROCESSED BY IB
Wednesday, September 4, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, September 4, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE